A271980 Stock Overview
Develops and supplies pharmaceutical products primarily in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Jeil Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩11,740.00 |
| 52 Week High | ₩19,870.00 |
| 52 Week Low | ₩10,120.00 |
| Beta | 1.05 |
| 1 Month Change | -5.32% |
| 3 Month Change | -21.37% |
| 1 Year Change | -31.35% |
| 3 Year Change | -65.32% |
| 5 Year Change | -66.84% |
| Change since IPO | -75.02% |
Recent News & Updates
Investors Don't See Light At End Of Jeil Pharmaceutical Co.,Ltd's (KRX:271980) Tunnel And Push Stock Down 27%
Dec 09
Is Jeil PharmaceuticalLtd (KRX:271980) A Risky Investment?
Nov 14Jeil Pharmaceutical Co.,Ltd's (KRX:271980) Business And Shares Still Trailing The Industry
Sep 08Recent updates
Investors Don't See Light At End Of Jeil Pharmaceutical Co.,Ltd's (KRX:271980) Tunnel And Push Stock Down 27%
Dec 09Is Jeil PharmaceuticalLtd (KRX:271980) A Risky Investment?
Nov 14Jeil Pharmaceutical Co.,Ltd's (KRX:271980) Business And Shares Still Trailing The Industry
Sep 08Is Jeil PharmaceuticalLtd (KRX:271980) Using Too Much Debt?
Apr 11Solid Earnings May Not Tell The Whole Story For Jeil PharmaceuticalLtd (KRX:271980)
Mar 19Shareholder Returns
| A271980 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -0.3% | -0.5% | -1.9% |
| 1Y | -31.3% | 0.8% | -9.5% |
Return vs Industry: A271980 underperformed the KR Pharmaceuticals industry which returned 0.8% over the past year.
Return vs Market: A271980 underperformed the KR Market which returned -9.5% over the past year.
Price Volatility
| A271980 volatility | |
|---|---|
| A271980 Average Weekly Movement | 5.1% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.8% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A271980 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A271980's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1959 | 1,000 | n/a | www.jeilpharm.co.kr |
Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company also exports its products to approximately 40 countries in ASEAN, Central and South America, Africa, and internationally.
Jeil Pharmaceutical Co.,Ltd Fundamentals Summary
| A271980 fundamental statistics | |
|---|---|
| Market cap | ₩171.07b |
| Earnings (TTM) | -₩35.82b |
| Revenue (TTM) | ₩697.64b |
0.2x
P/S Ratio-4.8x
P/E RatioIs A271980 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A271980 income statement (TTM) | |
|---|---|
| Revenue | ₩697.64b |
| Cost of Revenue | ₩527.59b |
| Gross Profit | ₩170.05b |
| Other Expenses | ₩205.88b |
| Earnings | -₩35.82b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.46k |
| Gross Margin | 24.38% |
| Net Profit Margin | -5.14% |
| Debt/Equity Ratio | 38.7% |
How did A271980 perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield-2%
Payout RatioDoes A271980 pay a reliable dividends?
See A271980 dividend history and benchmarks| Jeil PharmaceuticalLtd dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Apr 18 2025 |
| Days until Ex dividend | 0 days |
| Days until Dividend pay date | 112 days |
Does A271980 pay a reliable dividends?
See A271980 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 19:44 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jeil Pharmaceutical Co.,Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|